Infographic: Perceptions of Treatments in AML – A Survey of 375 European Haematologists - European Medical Journal

Infographic: Perceptions of Treatments in AML – A Survey of 375 European Haematologists

Hematology
Download PDF

Acute myeloid leukaemia (AML) is a rapidly progressing haematological cancer with a poor prognosis. This infographic summarises the key results from an online survey conducted in 2022 on the perceptions of AML treatments among clinicians in Europe. Haematologists and oncologists from five European countries were asked their opinions on topics such as first-line treatments, the intensity of treatment regimens, and therapies for curative intent for patients with AML.

This Infographic was developed and funded by Jazz Pharmaceuticals and is intended for European Healthcare Professionals only.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally

>